Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.43% | 22.21% | 92.20% | 92.08% | 280.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.43% | 22.21% | 92.20% | 92.08% | 280.97% |
| Cost of Revenue | 18.86% | 18.64% | 58.41% | 58.31% | 271.19% |
| Gross Profit | 50.65% | 50.37% | 213.73% | 213.66% | 429.46% |
| SG&A Expenses | -15.65% | -15.80% | 12.82% | 12.75% | 1,829.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 55.93% | 56.01% | -56.03% | -56.06% | -176.77% |
| Total Operating Expenses | 20.45% | 20.23% | 32.58% | 32.50% | 376.37% |
| Operating Income | 475.32% | 474.18% | 52.00% | 52.03% | 102.27% |
| Income Before Tax | -75.86% | -75.91% | -162.37% | -162.21% | 927.74% |
| Income Tax Expenses | -108.66% | -108.28% | -- | -- | 70.76% |
| Earnings from Continuing Operations | -75.30% | -75.34% | -431.53% | -431.22% | 1,009.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -187.45% |
| Net Income | -78.27% | -78.31% | -143.71% | -143.57% | 747.10% |
| EBIT | 475.32% | 474.18% | 52.00% | 52.03% | 102.27% |
| EBITDA | -19.85% | -20.00% | 82.64% | 82.65% | 648.01% |
| EPS Basic | -78.25% | -78.57% | -120.00% | -120.00% | 755.32% |
| Normalized Basic EPS | 62.50% | 62.50% | 59.26% | 59.26% | -77.78% |
| EPS Diluted | -89.86% | -89.86% | -140.00% | -140.00% | 393.62% |
| Normalized Diluted EPS | 86.67% | 86.67% | 59.26% | 59.26% | 16.67% |
| Average Basic Shares Outstanding | 0.48% | 0.48% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 125.86% | 125.86% | 0.00% | 0.00% | 116.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |